Gene therapy for rheumatoid arthritis

Expert Opinion on Biological Therapy

Volumn 1, Issue 6, 2001, Pages 971-978

  Gouze, Elvire ^a   Ghivizzani, Steven C ^a   Palmer, Glyn D ^a   Gouze, Jean Noel ^a,b   Robbins, Paul D ^c   Evans, Christopher H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

contralateral effect; gene therapy; IL 1 receptor antagonist; rheumatoid arthritis

Indexed keywords

CLINICAL TRIAL; DNA VECTOR; GENE THERAPY; HUMAN; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; GENE THERAPY; GENETIC VECTORS; HUMAN;

EID: 0035516173     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.1.6.971     Document Type: Article

References (55)

1. AREND WP: Cytokines and cellular interactions in inflammatory synovitis. J. Clin. Invest. (2001) 107:1081-1082.
2. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol. (1996) 14:397-440.
3. MORELAND LW, HECK LW Jr., KOOPMAN WJ: Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum. (1997) 40:397-409.
4. EVANS CH, GHIVIZZANI SC, KANG R et al.: Gene therapy for rheumatic diseases. Arthritis Rheum. (1999) 42:1-16.
5. GHIVIZZANI SC, OLIGINO TJ, GLORIOSO JC, ROBBINS PD, EVANS CH: Direct gene delivery strategies for the treatment of rheumatoid arthritis. Drug Discov. Today (2001) 6:259-267.
6. DOUGHTY LA, PATRENE KD, EVANS CH, BOGGS SS, ROBBINS PD: Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther. (1997) 4:252-257.
7. BOGGS SS, PATRENE KD, MUELLER GM, EVANS CH, DOUGHTY LA, ROBBINS PD: Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Gene Ther. (1995) 2:632-638.
8. BESSIS N, BOISSIER MC, FERRARA P, BLANKENSTEIN T, FRADELIZI D, FOURNIER C: Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. (1996) 26:2399-2403.
9. FELLOWES R, ETHERIDGE CJ, COADE S et al.: Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther. (2000) 7:967-977.
10. KIM SH, EVANS CH, KIM S, OLIGINO T, GHIVIZZANI SC, ROBBINS PD: Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Res. (2000) 2:293-302.
11. KIM SH, KIM S, EVANS CH, GHIVIZZANI SC, OLIGINO T, ROBBINS PD: Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J. Immunol. (2001) 166:3499-505.
12. LE CH, NICOLSON AG, MORALES A, SEWELL KL: Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene. Arthritis Rheum. (1997) 40:1662-1669.
13. QUATTROCCHI E, DALLMAN MJ, DHILLON A P, QUAGLIA A, BAGNATO G, FELDMANN M: Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J. Immunol. (2001) 166:5970-5978.
14. HUNG GL, GALEA-LAURI J, MUELLER GM et al.: Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther. (1994). 1:64-69.
15. OTANI K, NITA I, MACAULAY W, GEORGESCU HI, ROBBINS PD, EVANS CH: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J. Immunol. (1996) 156:3558-3562.
16. MAKAROV SS, OLSEN JC, JOHNSTON WN et al.: Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. USA (1996) 93:402-406.
17. BAKKER AC, JOOSTEN LA, ARNTZ OJ et al.: Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. (1997) 40:893-900.
18. EVANS CH, ROBBINS PD, GHIVIZZANI SC et al.: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther. (1996) 7:1261-1280.
19. EVANS CH, GHIVIZZANI SC, OLIGINO TA, ROBBINS PD: Future of adenoviruses in the gene therapy of arthritis. Arthritis Res. (2001) 3:142-146.
20. GHIVIZZANI SC, LECHMAN ER, KANG R et al.: Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA (1998) 95:4613-4618.
21. WOODS JM, KATSCHKE KJ, VOLIN MV et al.: IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J. Immunol. (2001) 166:1214-1222.
22. LECHMAN ER, JAFFURS D, GHIVIZZANI SC et al: Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J. Immunol. (1999) 163:2202-2208.
23. LUBBERTS E, JOOSTEN LA, VAN DEN BERSSELAAR L et al.: Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin. Exp. Immunol. (2000) 120:375-383.
24. MI Z, GHIVIZZANI SC, LECHMAN ER et al: Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum. (2000) 43:2563-2570.
25. YAO Q, WANG S, GLORIOSO JC et al: gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol. Ther (2001) 3:901-910.
26. HARTIGAN-O'CONNOR D, AMALFITANO A, CHAMBERLAIN JS: Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase. J. Virol. (1999) 73:7835-7841.
27. KOCHANEK S, CLEMENS PR, MITANI K, CHEN HH, CHAN S, CASKEY CT: A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA (1996) 93:5731-5736.
28. ROBBINS PD, GHIVIZZANI SC: Viral vectors for gene therapy. Pharmacol. Ther. (1998) 80:35-47.
29. NITA I, GHIVIZZANI SC, GALEA-LAURI J et al: Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. (1996) 39:820-828.
30. OLIGINO T, GHIVIZZANI S, WOLFE D et al: Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther. (1999) 6:1713-1720.
31. KRISKY DM, MARCONI PC, OLIGINO TJ et al: Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. (1998) 5:1517-1530.
32. GHIVIZZANI SC, LECHMAN ER, TIO C et al: Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy. Gene Ther. (1997) 4:977-982.
33. NGUYEN KH, BOYLE DL, MCCORMACK JE, CHADA S, JOLLY DJ, FIRESTEIN GS: Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis. J. Rheumatol. (1998) 25:1118-1125.
34. PAN RY, CHEN SL, XIAO X, LIU DW, PENG HJ, TSAO YP: Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum. (2000) 43:289-297.
35. PAN RY, XIAO X, CHEN SL et al: Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J. Virol. (1999) 73:3410-3417.
36. WATANABE S, IMAGAWA T, BOIVIN G P, GAO G, WILSON JM, HIRSCH R: Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol. Ther. (2000) 2:147-152.
37. JENNINGS K, KATAKURA S, BURSTEIN H, GAO G, WILSON JM, HIRSCH R: Adeno-associated virus preferentially transduces human compared to mouse synovium. Arthritis Res. (2001) 3(Suppl. 1):1.
38. GOATER J, MULLER R, KOLLIAS G et al.: Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J. Rheumatol. (2000) 27:983-989.
39. OLIGINO TJ, YAO Q, WANG S et al.: Intra-articular expression of the IL-1Ra gene following direct delivery with an adeno-associated virus vector. Gene Ther. (under revision).
40. NALDINI L, BLOMER U, GALLAY P et al.: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 272:263-267.
41. LEVER AM: Lentiviral vectors: progress and potential. Curr. Opin. Mol. Ther. (2000) 2:488-496.
42. BUCHSCHACHER GL Jr., WONG-STAAL F: Development of lentiviral vectors for gene therapy for human diseases. Blood (2000) 95:2499-2504.
43. ORY DS, NEUGEBOREN BA, MULLIGAN RC: A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA (1996) 93:11400-11406.
44. VIGNA E, NALDINI L: Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. (2000) 2:308-316.
45. GOUZE E, PAWLIUK R, PILAPIL C, GOUZE JN, LEBOULCH P, EVANS CH, GHIVIZZANI SC: In vitro and in vivo gene delivery using a lentiviral vector. Arthritis Res. (2001) 3:(Suppl. 1):34.
46. EVANS CH, ROBBINS PD, GHIVIZZANI SC et al.: Gene transfer to human joints: progress towards a gene therapy of arthritis. (Submitted for publication).
47. WHALEN JD, LECHMAN EL, CARLOS CA et al.: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and un-injected paws. J. Immunol. (1999) 162:3625-3632.
48. MIAGKOV AV, KOVALENKO DV, BROWN CE et al.: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA (1998) 95:13859-13864.
49. BOYLE DL, NGUYEN KH, ZHUANG S et al: Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity. Gene Ther. (1999) 6:1911-1918.
50. NAKAJIMA A, SEROOGY CM, SANDORA MR et al.: Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. (2001) 107:1293-1301.
51. MAGEED RA, ADAMS G, WOODROW D, PODHAJCER OL, CHERNAJOVSKY Y: Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Ther. (1998) 5:1584-1592.
52. DECARIS E, GUINGAMP C, CHAT M et al.: Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum. (1999) 42:1951-1960.
53. GOUZE-DECARIS E, PHILIPPE L, MINN A et al.: Neurophysiological basis for neurogenic-mediated articular cartilage anabolism alteration. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2001) 280:R115-122.
54. DAY CS, KASEMKIJWATTANA C, MENETREY J et al.: Myoblast-mediated gene transfer to the joint. J. Orthop. Res. (1997) 15:894-903.
55. YOO JU, MANDELL I, ANGELE P, JOHNSTONE B: Chondrogenitor cells and gene therapy. Clin. Orthop. (2000) S164-170.